Shetab R, Cohen S H, Prindiville T, Tang Y J, Cantrell M, Rahmani D, Silva J
Division of Infectious and Immunologic Diseases, University of California, Davis Medical Center, Sacramento 95817, USA.
J Clin Microbiol. 1998 Jun;36(6):1729-32. doi: 10.1128/JCM.36.6.1729-1732.1998.
Bacteroides fragilis constitutes about 1% of the bacterial flora in intestines of normal humans. Enterotoxigenic strains of B. fragilis have been associated with diarrheal diseases in humans and animals. The enterotoxin produced by these isolates induces fluid changes in ligated intestinal loops and an in vitro cytotoxic response in HT-29 cells. We developed a nested PCR to detect the enterotoxin gene of B. fragilis in stool specimens. After DNA extraction, a 367-bp fragment was amplified with two outer primers. The amplicon from this reaction was subjected to a second round of amplification with a set of internal primers. With these inner primers, a 290-bp DNA fragment was obtained which was confirmed as part of the B. fragilis enterotoxin gene by Southern blotting with a nonradioactive internal probe and a chemiluminescence system. By this approach, B. fragilis enterotoxin gene sequences were detected in eight known enterotoxigenic human isolates and nine enterotoxigenic horse isolates. No amplification products were obtained from DNA extracted from 28 nonenterotoxigenic B. fragilis isolates or B. distasonis, B. thetaiotaomicron, B. uniformis, B. ovatus, Escherichia coli, or Clostridium difficile. The sensitivity of this assay allowed us to detect as little as 1 pg of enterotoxin DNA sequences or 100 to 1,000 cells of enterotoxigenic B. fragilis/g of stool. Enterotoxin production of all isolates was confirmed in vitro in HT-29 cells. A 100% correlation was obtained between enterotoxin detection by cytotoxin assay and the nested PCR assay. This rapid and sensitive assay can be used to identify enterotoxigenic B. fragilis and may be used clinically to determine the role of B. fragilis in diarrheal diseases.
脆弱拟杆菌约占正常人类肠道细菌菌群的1%。产肠毒素的脆弱拟杆菌菌株与人类和动物的腹泻病有关。这些分离株产生的肠毒素可诱导结扎肠袢中的液体变化以及HT - 29细胞中的体外细胞毒性反应。我们开发了一种巢式PCR来检测粪便标本中脆弱拟杆菌的肠毒素基因。DNA提取后,用两个外部引物扩增出一个367 bp的片段。该反应的扩增产物用一组内部引物进行第二轮扩增。用这些内部引物获得了一个290 bp的DNA片段,通过用非放射性内部探针和化学发光系统进行Southern印迹证实其为脆弱拟杆菌肠毒素基因的一部分。通过这种方法,在8株已知的产肠毒素的人类分离株和9株产肠毒素的马分离株中检测到了脆弱拟杆菌肠毒素基因序列。从28株非产肠毒素的脆弱拟杆菌分离株或狄氏拟杆菌、多形拟杆菌、单形拟杆菌、卵形拟杆菌、大肠杆菌或艰难梭菌提取的DNA未获得扩增产物。该检测方法的灵敏度使我们能够检测到低至1 pg的肠毒素DNA序列或每克粪便中100至1000个产肠毒素的脆弱拟杆菌细胞。所有分离株的肠毒素产生在HT - 29细胞中进行了体外确认。细胞毒素测定法和巢式PCR测定法检测肠毒素的结果具有100%的相关性。这种快速灵敏的检测方法可用于鉴定产肠毒素的脆弱拟杆菌,临床上可用于确定脆弱拟杆菌在腹泻病中的作用。